1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Clore, G.M.
Powers, B.
Garrett, D.S.
Gronenborn, A.M.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
32
6744
6762
10.1021/bi00077a030
8329398
The high-resolution, three-dimensional solution structure of human interleukin-4 determined by multidimensional heteronuclear magnetic resonance spectroscopy.
1993
US
Science
SCIEAS
0038
0036-8075
256
1673
Three-Dimensional Solution Structure of Human Interleukin-4 by Multidimensional Heteronuclear Magnetic Resonance Spectroscopy
1992
US
Biochemistry
BICHAW
0033
0006-2960
31
4334
1H, 15N, 13C and 13Co Assignments of Human Interleukin-4 Using Three Dimensional Double-and Triple-Resonance Heteronuclear Magnetic Resonance Spectroscopy
1992
US
Biochemistry
BICHAW
0033
0006-2960
31
4347
Determination of the Secondary Structure and Folding Topology of Human Interleukin-4 Using Three-Dimensional Heteronuclear Magnetic Resonance Spectroscopy
1992
10.2210/pdb1iti/pdb
pdb_00001iti
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
15391.601
INTERLEUKIN-4
1
man
polymer
no
no
EAEAHKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKDTTEKETFCRAATVLRQFYSHHEKDTRCLGATAQQFHRH
KQLIRFLKRLDRNLWGLAGLNSCPVKEADQSTLENFLERLKTIMREKYSKCSS
EAEAHKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKDTTEKETFCRAATVLRQFYSHHEKDTRCLGATAQQFHRH
KQLIRFLKRLDRNLWGLAGLNSCPVKEADQSTLENFLERLKTIMREKYSKCSS
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
POTENTIAL
9606
Homo sapiens
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1993-07-15
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_ref_seq_dif.details
Y
BNL
1993-04-12
REL
THE NUMBERING SCHEME IN THIS STRUCTURE INCLUDES THE
FOUR-RESIDUE SEQUENCE GLU-ALA-GLU-ALA AT THE N-TERMINUS OF
THE RECOMBINANT PROTEIN WHICH IS NOT PART OF THE NATURAL
HUMAN IL-4; THE NATURAL IL-4 SEQUENCE THEREFORE STARTS AT
RESIDUE 5.
THE TWO POTENTIAL N-LINKED GLYCOSYLATION SITES AT ASN 42
AND ASN 109 IN THE NATURAL SEQUENCE WERE CHANGED TO ASP TO
PREVENT HYPERGLYCOSYLATION IN THE YEAST HOST.
31
DETAILS OF THE STRUCTURE DETERMINATION AND ALL STRUCTURAL
STATISTICS ARE GIVEN IN THE REFERENCE LISTED ON THE JRNL
RECORDS ABOVE (I.E. AGREEMENT WITH EXPERIMENTAL RESTRAINTS,
DEVIATIONS FROM IDEALITY FOR BOND LENGTHS, ANGLES, PLANES
AND CHIRALITY, NON-BONDED CONTACTS, ATOMIC RMS DIFFERENCES
BETWEEN THE CALCULATED STRUCTURES).
THE STRUCTURES ARE BASED ON A TOTAL OF 2973 EXPERIMENTAL
NMR RESTRAINTS COMPRISING: 2515 INTERPROTON DISTANCE
RESTRAINTS DERIVED FROM NOE MEASUREMENTS; 102
HYDROGEN-BONDING DISTANCE RESTRAINTS FOR 51 HYDROGEN-BONDS
IDENTIFIED ON THE BASIS OF THE NOE AND AMIDE PROTON
EXCHANGE DATA, AS WELL AS THE INITIAL STRUCTURE
CALCULATIONS; AND 130 PHI, 119 PSI, 73 CHI1, 32 CHI2 AND
2 CHI3 TORSION ANGLE RESTRAINTS DERIVED FROM COUPLING
CONSTANTS, NOE DATA, AND 13C SECONDARY CHEMICAL SHIFTS.
THE METHOD USED TO DETERMINE THE STRUCTURES IS THE HYBRID
METRIC MATRIX DISTANCE GEOMETRY-DYNAMICAL SIMULATED
ANNEALING METHOD [NILGES, M., CLORE, G.M. & GRONENBORN,
A.M., FEBS LETT. 229, 317-324 (1988)].
A TOTAL OF 30 STRUCTURES WERE CALCULATED. THE ATOMIC RMS
DISTRIBUTION ABOUT THE MEAN COORDINATE POSITIONS FOR
RESIDUES 8 - 129 IS 0.44 (+/-0.03) ANGSTROMS FOR THE
BACKBONE ATOMS, 0.83 (+/-0.03) ANGSTROMS FOR ALL ATOMS,
AND 0.51 (+/-0.04) ANGSTROMS FOR ALL ATOMS EXCLUDING
DISORDERED SIDE CHAINS. THE N- (RESIDUES 1 - 7) AND C-
(RESIDUES 130 - 133) TERMINAL RESIDUES ARE DISORDERED.
THE COORDINATES OF THE RESTRAINED MINIMIZED STRUCTURE ARE
LISTED FIRST AS MODEL 0. THIS (SA)R RESTRAINED MINIMIZED
MEAN STRUCTURE WAS DERIVED BY AVERAGING THE COORDINATES OF
THE INDIVIDUAL SA STRUCTURES (BEST FITTED TO RESIDUES 8 -
129) AND SUBJECTING THE RESULTING COORDINATES TO RESTRAINED
MINIMIZATION. THE QUANTITY PRESENTED IN THE TEMPERATURE
FACTOR FIELD (COLUMNS 61 - 66) REPRESENTS THE ATOMIC RMS
DEVIATIONS OF THE 30 INDIVIDUAL SA STRUCTURES ABOUT THE
MEAN STRUCTURE. RESIDUES 1 - 7 AND 130 - 133 AT THE N-
AND C-TERMINI, RESPECTIVELY, ARE DISORDERED.
GLU
1
n
1
GLU
1
A
ALA
2
n
2
ALA
2
A
GLU
3
n
3
GLU
3
A
ALA
4
n
4
ALA
4
A
HIS
5
n
5
HIS
5
A
LYS
6
n
6
LYS
6
A
CYS
7
n
7
CYS
7
A
ASP
8
n
8
ASP
8
A
ILE
9
n
9
ILE
9
A
THR
10
n
10
THR
10
A
LEU
11
n
11
LEU
11
A
GLN
12
n
12
GLN
12
A
GLU
13
n
13
GLU
13
A
ILE
14
n
14
ILE
14
A
ILE
15
n
15
ILE
15
A
LYS
16
n
16
LYS
16
A
THR
17
n
17
THR
17
A
LEU
18
n
18
LEU
18
A
ASN
19
n
19
ASN
19
A
SER
20
n
20
SER
20
A
LEU
21
n
21
LEU
21
A
THR
22
n
22
THR
22
A
GLU
23
n
23
GLU
23
A
GLN
24
n
24
GLN
24
A
LYS
25
n
25
LYS
25
A
THR
26
n
26
THR
26
A
LEU
27
n
27
LEU
27
A
CYS
28
n
28
CYS
28
A
THR
29
n
29
THR
29
A
GLU
30
n
30
GLU
30
A
LEU
31
n
31
LEU
31
A
THR
32
n
32
THR
32
A
VAL
33
n
33
VAL
33
A
THR
34
n
34
THR
34
A
ASP
35
n
35
ASP
35
A
ILE
36
n
36
ILE
36
A
PHE
37
n
37
PHE
37
A
ALA
38
n
38
ALA
38
A
ALA
39
n
39
ALA
39
A
SER
40
n
40
SER
40
A
LYS
41
n
41
LYS
41
A
ASP
42
n
42
ASP
42
A
THR
43
n
43
THR
43
A
THR
44
n
44
THR
44
A
GLU
45
n
45
GLU
45
A
LYS
46
n
46
LYS
46
A
GLU
47
n
47
GLU
47
A
THR
48
n
48
THR
48
A
PHE
49
n
49
PHE
49
A
CYS
50
n
50
CYS
50
A
ARG
51
n
51
ARG
51
A
ALA
52
n
52
ALA
52
A
ALA
53
n
53
ALA
53
A
THR
54
n
54
THR
54
A
VAL
55
n
55
VAL
55
A
LEU
56
n
56
LEU
56
A
ARG
57
n
57
ARG
57
A
GLN
58
n
58
GLN
58
A
PHE
59
n
59
PHE
59
A
TYR
60
n
60
TYR
60
A
SER
61
n
61
SER
61
A
HIS
62
n
62
HIS
62
A
HIS
63
n
63
HIS
63
A
GLU
64
n
64
GLU
64
A
LYS
65
n
65
LYS
65
A
ASP
66
n
66
ASP
66
A
THR
67
n
67
THR
67
A
ARG
68
n
68
ARG
68
A
CYS
69
n
69
CYS
69
A
LEU
70
n
70
LEU
70
A
GLY
71
n
71
GLY
71
A
ALA
72
n
72
ALA
72
A
THR
73
n
73
THR
73
A
ALA
74
n
74
ALA
74
A
GLN
75
n
75
GLN
75
A
GLN
76
n
76
GLN
76
A
PHE
77
n
77
PHE
77
A
HIS
78
n
78
HIS
78
A
ARG
79
n
79
ARG
79
A
HIS
80
n
80
HIS
80
A
LYS
81
n
81
LYS
81
A
GLN
82
n
82
GLN
82
A
LEU
83
n
83
LEU
83
A
ILE
84
n
84
ILE
84
A
ARG
85
n
85
ARG
85
A
PHE
86
n
86
PHE
86
A
LEU
87
n
87
LEU
87
A
LYS
88
n
88
LYS
88
A
ARG
89
n
89
ARG
89
A
LEU
90
n
90
LEU
90
A
ASP
91
n
91
ASP
91
A
ARG
92
n
92
ARG
92
A
ASN
93
n
93
ASN
93
A
LEU
94
n
94
LEU
94
A
TRP
95
n
95
TRP
95
A
GLY
96
n
96
GLY
96
A
LEU
97
n
97
LEU
97
A
ALA
98
n
98
ALA
98
A
GLY
99
n
99
GLY
99
A
LEU
100
n
100
LEU
100
A
ASN
101
n
101
ASN
101
A
SER
102
n
102
SER
102
A
CYS
103
n
103
CYS
103
A
PRO
104
n
104
PRO
104
A
VAL
105
n
105
VAL
105
A
LYS
106
n
106
LYS
106
A
GLU
107
n
107
GLU
107
A
ALA
108
n
108
ALA
108
A
ASP
109
n
109
ASP
109
A
GLN
110
n
110
GLN
110
A
SER
111
n
111
SER
111
A
THR
112
n
112
THR
112
A
LEU
113
n
113
LEU
113
A
GLU
114
n
114
GLU
114
A
ASN
115
n
115
ASN
115
A
PHE
116
n
116
PHE
116
A
LEU
117
n
117
LEU
117
A
GLU
118
n
118
GLU
118
A
ARG
119
n
119
ARG
119
A
LEU
120
n
120
LEU
120
A
LYS
121
n
121
LYS
121
A
THR
122
n
122
THR
122
A
ILE
123
n
123
ILE
123
A
MET
124
n
124
MET
124
A
ARG
125
n
125
ARG
125
A
GLU
126
n
126
GLU
126
A
LYS
127
n
127
LYS
127
A
TYR
128
n
128
TYR
128
A
SER
129
n
129
SER
129
A
LYS
130
n
130
LYS
130
A
CYS
131
n
131
CYS
131
A
SER
132
n
132
SER
132
A
SER
133
n
133
SER
133
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
VAL
33
A
N
VAL
33
A
O
SER
111
A
O
SER
111
2
A
A
H
HZ1
ASP
LYS
8
130
1.30
6
A
A
H
HZ3
ASP
LYS
8
130
1.34
8
A
A
HG
H
SER
SER
132
133
1.33
9
A
A
HG1
H
THR
GLN
73
76
1.31
10
A
A
H1
H
GLU
ALA
1
2
1.31
17
A
A
HG1
H
THR
CYS
26
28
1.31
18
A
A
HH11
HD22
ARG
ASN
89
93
1.31
1
A
ALA
2
-51.80
-105.33
1
A
ALA
4
-169.16
-23.58
1
A
LYS
6
-67.08
25.26
1
A
ALA
39
-157.69
43.39
1
A
LYS
41
-130.05
-81.90
1
A
LYS
46
-52.72
-70.26
1
A
PHE
59
-83.19
-70.94
1
A
ARG
68
-100.25
-61.24
1
A
ALA
72
-138.47
-30.58
1
A
ARG
89
-83.71
-71.92
1
A
TRP
95
-56.86
-8.61
1
A
CYS
103
-160.33
65.71
1
A
LYS
106
-103.52
-130.13
1
A
ASP
109
-83.63
-105.43
1
A
GLU
114
-68.45
-74.83
1
A
TYR
128
-65.42
7.34
1
A
LYS
130
-156.61
-124.34
1
A
SER
132
-105.38
74.13
2
A
ALA
4
-159.04
-147.99
2
A
ALA
38
-77.30
27.89
2
A
ALA
39
-147.75
10.52
2
A
SER
40
-55.62
105.52
2
A
LYS
41
-145.18
-89.72
2
A
GLU
64
-47.27
-16.95
2
A
THR
67
-93.13
43.17
2
A
ARG
68
-95.76
-62.18
2
A
ALA
72
-147.37
-35.25
2
A
THR
73
-48.11
164.19
2
A
ARG
89
-90.09
-77.63
2
A
LEU
94
-58.35
-71.01
2
A
TRP
95
-48.54
-14.19
2
A
LEU
97
-59.83
-1.43
2
A
ALA
98
-81.88
-73.85
2
A
ASN
101
-87.66
-88.62
2
A
CYS
103
-159.34
68.20
2
A
LYS
106
-92.70
-106.85
2
A
ALA
108
179.37
172.99
2
A
ASP
109
-92.59
-120.54
2
A
LYS
130
-175.28
-115.44
2
A
SER
132
-147.56
56.59
3
A
GLN
12
-78.94
-71.00
3
A
ALA
39
-165.01
89.93
3
A
LYS
41
-145.70
-70.63
3
A
PHE
59
-83.56
-70.24
3
A
GLU
64
-47.58
-18.94
3
A
THR
67
-95.69
37.83
3
A
ARG
68
-93.77
-70.42
3
A
LEU
70
-94.52
-66.00
3
A
ARG
89
-76.07
-70.08
3
A
LEU
97
-59.06
-2.23
3
A
ALA
98
-90.03
-77.92
3
A
ASN
101
-69.48
-77.84
3
A
LYS
106
-92.84
-130.32
3
A
ALA
108
169.96
168.44
3
A
ASP
109
-93.10
-104.73
3
A
GLU
114
-64.54
-75.66
3
A
TYR
128
-69.59
10.45
3
A
LYS
130
-170.19
-149.78
3
A
CYS
131
-47.50
-15.68
3
A
SER
132
-89.58
36.06
4
A
LEU
11
-48.74
-16.98
4
A
LYS
25
-150.84
84.11
4
A
CYS
28
-58.00
-7.60
4
A
GLU
30
-67.25
6.52
4
A
ILE
36
-146.81
-34.86
4
A
ALA
39
-161.98
37.36
4
A
ASP
42
-148.12
29.02
4
A
THR
44
-60.67
-166.47
4
A
THR
67
-94.12
40.82
4
A
ARG
89
-85.28
-75.07
4
A
LEU
94
-57.10
-70.82
4
A
TRP
95
-51.62
-9.60
4
A
LEU
97
-59.77
-1.54
4
A
ALA
98
-82.42
-70.84
4
A
CYS
103
-165.09
68.43
4
A
LYS
106
-142.27
-127.46
4
A
ALA
108
-171.66
-143.44
4
A
ASP
109
-92.59
-142.29
4
A
GLU
114
-68.84
-75.34
4
A
LYS
130
-171.18
-150.36
5
A
GLU
3
-155.48
-1.46
5
A
ALA
4
-155.45
72.54
5
A
LYS
6
-147.48
19.82
5
A
CYS
28
-65.04
2.28
5
A
ASP
35
-49.15
175.34
5
A
ILE
36
-146.56
-35.09
5
A
ALA
39
-154.70
11.88
5
A
LYS
41
-149.11
-80.48
5
A
PHE
59
-84.73
-70.29
5
A
HIS
62
-90.05
-61.34
5
A
THR
67
-76.12
40.04
5
A
ALA
72
-147.61
-35.29
5
A
THR
73
-49.59
164.43
5
A
LEU
94
-59.06
-73.91
5
A
TRP
95
-47.43
-16.33
5
A
ASN
101
-88.04
-94.42
5
A
CYS
103
-164.88
68.06
5
A
LYS
106
-92.54
-129.91
5
A
ALA
108
170.03
130.33
5
A
ASP
109
-72.90
-118.41
5
A
GLU
114
-76.18
-76.34
5
A
TYR
128
-68.34
8.44
5
A
SER
129
-90.00
51.96
5
A
LYS
130
-92.48
-111.91
6
A
GLU
3
-140.99
-21.35
6
A
LEU
31
-62.08
-169.98
6
A
ASP
35
-47.65
171.12
6
A
ILE
36
-147.21
-34.50
6
A
ALA
39
-151.04
-10.01
6
A
LYS
41
-146.70
-39.65
6
A
ASP
42
-148.71
16.55
6
A
THR
44
-77.37
-147.94
6
A
THR
67
-91.25
45.41
6
A
ARG
89
-90.08
-65.78
6
A
TRP
95
-55.69
-9.96
6
A
LEU
97
-59.57
-1.53
6
A
CYS
103
-164.94
68.25
6
A
LYS
106
-144.39
-131.40
6
A
ALA
108
-172.14
-140.09
6
A
ASP
109
-92.88
-122.30
6
A
GLU
114
-70.14
-75.00
6
A
GLU
118
-70.71
-70.09
6
A
SER
129
-73.69
20.53
6
A
LYS
130
-59.06
-110.78
7
A
ALA
4
-177.70
-7.60
7
A
LEU
11
-48.42
-15.37
7
A
THR
26
-92.95
-155.25
7
A
ILE
36
-146.99
-34.85
7
A
ALA
39
-157.46
14.90
7
A
LYS
41
-147.45
-76.99
7
A
PHE
59
-84.40
-74.14
7
A
THR
67
-75.58
36.32
7
A
ALA
72
-101.08
-67.00
7
A
THR
73
-49.41
176.17
7
A
ARG
89
-87.43
-71.61
7
A
TRP
95
-56.07
-5.60
7
A
LEU
97
-59.64
-1.21
7
A
ASN
101
-92.43
-63.49
7
A
CYS
103
-162.84
68.05
7
A
LYS
106
-92.51
-130.07
7
A
ALA
108
174.92
153.13
7
A
ASP
109
-92.26
-116.98
7
A
GLU
114
-71.56
-72.25
7
A
LYS
130
-178.51
-106.71
7
A
SER
132
-153.34
72.43
8
A
GLU
3
-64.20
2.82
8
A
LYS
25
-150.80
88.74
8
A
ILE
36
-147.39
-35.07
8
A
ALA
39
-148.33
34.10
8
A
LYS
41
-86.99
-89.94
8
A
ARG
57
-62.10
-70.17
8
A
PHE
59
-85.08
-76.63
8
A
THR
67
-90.40
45.05
8
A
ARG
68
-95.80
-60.15
8
A
ALA
72
-148.27
-35.85
8
A
THR
73
-57.34
176.08
8
A
ARG
89
-90.07
-77.53
8
A
LEU
97
-59.46
-1.95
8
A
ASN
101
-93.00
-90.92
8
A
CYS
103
-164.91
68.12
8
A
LYS
106
-85.66
-107.17
8
A
ASP
109
-92.55
-110.22
8
A
GLU
114
-72.91
-76.90
8
A
TYR
128
-69.27
10.01
8
A
LYS
130
-165.59
-150.80
8
A
SER
132
-95.68
-155.45
9
A
ALA
2
-157.02
-91.95
9
A
GLU
3
-141.74
-72.99
9
A
ALA
4
-91.13
-99.49
9
A
HIS
5
-60.57
-156.25
9
A
LYS
6
-147.55
52.23
9
A
LYS
25
-151.16
85.73
9
A
GLU
30
-49.68
-13.91
9
A
ILE
36
-145.89
-33.56
9
A
SER
40
-57.97
83.43
9
A
ASP
42
-147.98
59.92
9
A
LYS
46
-46.96
-75.18
9
A
PHE
59
-85.10
-74.20
9
A
GLU
64
-47.27
-19.24
9
A
THR
67
-78.46
29.89
9
A
ARG
68
-93.37
-68.82
9
A
CYS
69
-65.07
0.90
9
A
ALA
72
-147.03
-36.28
9
A
LEU
97
-59.78
-1.51
9
A
ALA
98
-82.08
-74.00
9
A
ASN
101
-92.79
-62.54
9
A
CYS
103
-153.48
67.78
9
A
LYS
106
-144.55
-130.11
9
A
ALA
108
169.96
161.07
9
A
ASP
109
-76.41
-142.50
9
A
GLU
114
-69.30
-73.37
9
A
SER
129
-74.41
31.32
9
A
LYS
130
-75.01
-99.79
10
A
CYS
28
-66.82
2.05
10
A
GLU
30
-55.96
-5.78
10
A
ALA
39
-163.83
88.37
10
A
ASP
42
-147.85
21.58
10
A
THR
44
-70.43
-169.73
10
A
PHE
59
-82.93
-75.78
10
A
THR
67
-81.39
42.30
10
A
CYS
103
-165.06
68.20
10
A
LYS
106
-142.09
-131.33
10
A
ALA
108
170.11
-174.07
10
A
ASP
109
-67.24
-148.18
10
A
GLU
114
-69.30
-71.10
10
A
TYR
128
-69.88
1.40
10
A
LYS
130
-162.28
-130.33
11
A
ALA
2
-177.51
53.17
11
A
GLU
3
-154.11
-20.79
11
A
ILE
36
-147.18
-35.06
11
A
ALA
39
-156.22
49.77
11
A
LYS
41
-92.57
-81.73
11
A
PHE
59
-84.23
-70.66
11
A
GLU
64
-47.43
-15.61
11
A
THR
67
-100.31
47.54
11
A
ARG
68
-100.16
-77.19
11
A
CYS
69
-52.50
-7.84
11
A
ARG
89
-90.09
-70.04
11
A
TRP
95
-47.97
-14.89
11
A
LEU
97
-59.93
-1.56
11
A
ALA
98
-82.05
-70.17
11
A
ASN
101
-92.62
-69.55
11
A
CYS
103
-164.31
67.97
11
A
LYS
106
-145.74
-129.98
11
A
ALA
108
170.19
134.56
11
A
ASP
109
-61.56
-147.05
11
A
GLU
114
-70.65
-77.55
11
A
LYS
130
-168.94
-133.12
11
A
SER
132
-87.04
36.09
12
A
ALA
2
-81.20
-152.43
12
A
ALA
4
-147.60
-94.31
12
A
HIS
5
-59.26
179.53
12
A
LYS
6
-144.38
15.96
12
A
LEU
31
-59.89
-170.27
12
A
ALA
39
-155.58
28.66
12
A
LYS
41
-147.50
-89.70
12
A
PHE
59
-83.28
-73.55
12
A
THR
67
-95.53
41.98
12
A
ARG
68
-94.89
-63.96
12
A
LEU
70
-94.55
-66.68
12
A
TRP
95
-53.63
-9.10
12
A
LEU
97
-59.76
-1.37
12
A
ALA
98
-79.29
-71.47
12
A
ASN
101
-89.92
-78.82
12
A
CYS
103
-165.01
68.10
12
A
LYS
106
-92.67
-130.09
12
A
ALA
108
-152.24
-144.81
12
A
ASP
109
-91.24
-134.35
12
A
GLU
114
-67.63
-76.50
12
A
GLU
118
-62.91
-70.11
12
A
LYS
130
-147.85
-118.88
13
A
ALA
4
-148.83
-29.02
13
A
CYS
28
-66.42
1.49
13
A
ILE
36
-147.34
-35.42
13
A
ALA
39
-162.01
47.71
13
A
LYS
41
-92.77
-85.10
13
A
HIS
62
-90.27
-60.03
13
A
THR
67
-76.62
41.19
13
A
ALA
72
-146.92
-35.16
13
A
ARG
89
-86.48
-74.03
13
A
TRP
95
-57.32
-4.34
13
A
LEU
97
-59.76
-1.53
13
A
ALA
98
-81.66
-73.27
13
A
ASN
101
-72.28
-70.88
13
A
CYS
103
-164.96
68.24
13
A
LYS
106
-82.43
-130.00
13
A
ALA
108
-163.24
-163.43
13
A
ASP
109
-92.67
-121.47
13
A
TYR
128
-62.39
0.86
13
A
LYS
130
-174.18
-105.29
13
A
SER
132
-95.70
-155.48
14
A
ALA
4
-176.90
44.02
14
A
ALA
39
-164.99
46.25
14
A
LYS
41
-91.99
-89.99
14
A
THR
43
-51.19
-179.97
14
A
THR
67
-92.03
44.33
14
A
ARG
68
-94.54
-62.21
14
A
ALA
72
-147.28
-35.78
14
A
ARG
89
-76.50
-70.60
14
A
LEU
97
-59.98
-1.70
14
A
ALA
98
-85.59
-75.65
14
A
ASN
101
-78.17
-78.77
14
A
CYS
103
-165.04
68.15
14
A
LYS
106
-92.74
-130.14
14
A
ALA
108
171.47
149.83
14
A
ASP
109
-92.67
-100.37
14
A
GLU
114
-58.07
-70.71
14
A
TYR
128
-69.31
10.22
14
A
LYS
130
-64.64
-126.16
14
A
CYS
131
-64.88
3.89
14
A
SER
132
-95.33
-155.40
15
A
LYS
6
-92.59
41.59
15
A
LEU
11
-47.62
-19.11
15
A
GLN
12
-78.76
-70.30
15
A
ILE
36
-150.93
-35.30
15
A
ALA
39
-158.21
29.40
15
A
LYS
41
-92.47
-89.88
15
A
LYS
46
-60.91
-70.48
15
A
THR
67
-93.55
45.40
15
A
ALA
72
-146.52
-35.16
15
A
LYS
88
-49.51
-18.51
15
A
ARG
89
-90.14
-77.48
15
A
TRP
95
-47.37
-19.44
15
A
ASN
101
-120.04
-75.64
15
A
CYS
103
-154.60
68.01
15
A
LYS
106
-141.46
-91.82
15
A
ALA
108
171.08
151.55
15
A
ASP
109
-61.74
-121.11
15
A
GLU
114
-71.27
-75.48
15
A
TYR
128
-69.53
8.82
15
A
SER
129
-54.40
-80.72
15
A
LYS
130
36.86
-143.34
16
A
ALA
4
-148.79
-17.05
16
A
LYS
6
-158.82
13.76
16
A
GLN
12
-80.93
-70.59
16
A
ALA
39
-164.95
89.75
16
A
PHE
59
-85.17
-74.73
16
A
THR
67
-93.04
39.33
16
A
LEU
70
-95.83
-109.46
16
A
ALA
72
-174.46
-31.09
16
A
LEU
97
-59.59
-1.44
16
A
CYS
103
-164.54
68.12
16
A
LYS
106
-92.12
-130.08
16
A
ALA
108
-156.34
-157.99
16
A
ASP
109
-92.83
-118.08
16
A
GLU
114
-68.39
-75.38
16
A
LYS
130
-156.58
-102.77
17
A
ALA
4
-92.65
41.65
17
A
LYS
6
-147.47
15.87
17
A
LEU
31
-59.89
-169.88
17
A
ILE
36
-145.09
-34.36
17
A
LYS
41
-88.12
-71.60
17
A
PHE
59
-82.12
-71.44
17
A
HIS
62
-90.22
-62.53
17
A
THR
67
-93.21
41.62
17
A
ALA
72
-172.32
-31.34
17
A
THR
73
-47.25
166.63
17
A
ARG
89
-84.59
-75.16
17
A
LEU
97
-59.43
-1.89
17
A
ASN
101
-92.82
-68.37
17
A
CYS
103
-164.97
68.08
17
A
LYS
106
-141.21
-126.93
17
A
ALA
108
-167.60
-155.35
17
A
ASP
109
-92.75
-130.75
17
A
GLU
114
-60.62
-73.36
17
A
LYS
130
-169.18
-151.45
17
A
CYS
131
-47.32
-19.27
17
A
SER
132
-92.64
36.82
18
A
ALA
2
-158.04
2.27
18
A
ILE
36
-145.36
-34.76
18
A
ALA
39
-158.70
27.39
18
A
LYS
41
-92.58
-90.08
18
A
THR
44
-80.96
-142.44
18
A
PHE
59
-82.87
-78.82
18
A
GLU
64
-47.49
-15.39
18
A
THR
67
-95.20
32.59
18
A
ARG
68
-92.27
-73.06
18
A
CYS
69
-58.38
-4.21
18
A
ALA
72
-147.37
-35.07
18
A
THR
73
-49.07
165.70
18
A
LEU
97
-59.63
-1.33
18
A
ALA
98
-77.95
-71.50
18
A
ASN
101
-80.83
-76.77
18
A
CYS
103
-164.89
68.28
18
A
LYS
106
-87.83
-103.87
18
A
ALA
108
178.87
164.18
18
A
ASP
109
-76.75
-96.17
18
A
GLN
110
-170.95
147.00
18
A
GLU
114
-73.20
-70.90
18
A
TYR
128
-64.11
2.79
18
A
SER
129
-81.65
47.05
18
A
LYS
130
-92.35
-111.82
19
A
ALA
2
-163.16
-94.10
19
A
ALA
4
-162.50
28.37
19
A
LYS
6
-93.04
31.11
19
A
GLN
12
-76.36
-70.40
19
A
GLU
13
-48.64
-17.87
19
A
GLU
30
-61.91
0.49
19
A
ALA
39
-162.49
89.33
19
A
ASP
42
-157.25
35.09
19
A
THR
44
-82.17
-141.96
19
A
PHE
59
-85.19
-74.01
19
A
THR
67
-92.77
36.74
19
A
LYS
88
-47.41
-18.00
19
A
ARG
89
-85.35
-72.02
19
A
TRP
95
-56.14
-9.84
19
A
LEU
97
-59.81
-1.66
19
A
ALA
98
-83.30
-71.48
19
A
ASN
101
-77.21
-70.88
19
A
CYS
103
-164.65
67.85
19
A
LYS
106
-93.88
-114.83
19
A
ASP
109
-72.07
-121.57
19
A
GLU
114
-72.60
-74.17
19
A
LYS
130
31.57
-111.42
20
A
ALA
2
-169.59
5.39
20
A
ALA
4
-160.89
-7.69
20
A
LYS
6
-92.79
32.16
20
A
GLU
30
-62.20
0.56
20
A
ILE
36
-146.76
-35.39
20
A
ALA
39
-161.65
44.15
20
A
LYS
41
-86.21
-90.10
20
A
PHE
59
-85.24
-73.54
20
A
THR
67
-93.24
46.55
20
A
ARG
89
-90.02
-69.30
20
A
LEU
97
-59.62
-1.49
20
A
ALA
98
-79.60
-72.55
20
A
CYS
103
-165.07
67.79
20
A
LYS
106
-92.22
-115.12
20
A
ALA
108
-172.27
-164.66
20
A
ASP
109
-83.28
-127.62
20
A
GLU
114
-69.30
-75.74
20
A
TYR
128
-76.78
21.51
20
A
LYS
130
-157.19
-150.27
20
A
CYS
131
-47.05
-15.90
20
A
SER
132
-79.64
35.95
21
A
GLU
3
-171.16
94.52
21
A
ALA
4
-171.33
107.76
21
A
LYS
6
-160.96
8.80
21
A
ASP
35
-51.03
170.61
21
A
ILE
36
-146.92
-34.93
21
A
LYS
41
-91.09
-82.37
21
A
PHE
59
-85.09
-70.18
21
A
HIS
62
-90.29
-61.18
21
A
THR
67
-76.00
39.47
21
A
ARG
68
-79.97
-76.86
21
A
CYS
69
-95.97
30.65
21
A
ALA
72
-146.91
-35.72
21
A
ARG
89
-89.44
-77.14
21
A
TRP
95
-48.61
-14.11
21
A
ALA
98
-88.03
-75.73
21
A
CYS
103
-165.03
68.12
21
A
LYS
106
-141.16
-107.33
21
A
ALA
108
175.51
177.84
21
A
ASP
109
-83.99
-107.79
21
A
GLN
110
-171.17
145.53
21
A
GLU
114
-72.14
-74.95
21
A
LYS
130
-169.81
-134.75
21
A
CYS
131
-74.88
27.15
21
A
SER
132
-156.83
87.03
22
A
GLU
3
-170.58
75.83
22
A
HIS
5
-147.63
-156.23
22
A
LYS
6
-147.67
26.82
22
A
GLU
30
-52.34
-9.50
22
A
ALA
39
-164.70
46.01
22
A
LYS
41
-147.79
-86.97
22
A
PHE
59
-85.17
-73.56
22
A
THR
67
-94.08
39.52
22
A
ARG
68
-90.79
-60.63
22
A
LEU
70
-95.29
-71.29
22
A
THR
73
-47.14
152.91
22
A
ARG
89
-90.12
-73.54
22
A
LEU
97
-59.75
-1.56
22
A
ALA
98
-81.10
-70.54
22
A
ASN
101
-90.96
-69.75
22
A
CYS
103
-164.83
68.05
22
A
LYS
106
-92.19
-117.29
22
A
ALA
108
173.12
-177.92
22
A
ASP
109
-77.98
-119.39
22
A
TYR
128
-68.45
8.53
22
A
LYS
130
-164.13
-101.90
22
A
SER
132
-95.76
-155.39
23
A
ALA
4
-63.63
-90.49
23
A
HIS
5
-59.79
-155.21
23
A
LYS
6
-144.23
38.55
23
A
LYS
25
-151.30
82.14
23
A
CYS
28
-65.46
4.41
23
A
ILE
36
-144.76
-35.27
23
A
ALA
39
-164.03
33.09
23
A
LYS
41
-148.41
-84.26
23
A
THR
44
-70.83
-157.55
23
A
PHE
59
-85.06
-71.71
23
A
THR
67
-92.43
47.99
23
A
ALA
72
-165.82
-34.50
23
A
THR
73
-60.04
-179.91
23
A
ARG
89
-79.18
-72.32
23
A
LEU
90
-57.38
-5.53
23
A
LEU
97
-59.58
-1.37
23
A
ALA
98
-81.13
-73.26
23
A
ASN
101
-92.59
-66.05
23
A
CYS
103
-157.88
67.97
23
A
LYS
106
-92.31
-130.08
23
A
ALA
108
170.08
140.37
23
A
ASP
109
-71.08
-126.37
23
A
LYS
130
-171.41
-152.27
23
A
CYS
131
-48.62
-14.64
23
A
SER
132
-87.48
36.05
24
A
ALA
2
-148.93
29.80
24
A
GLU
30
-55.98
-9.55
24
A
LEU
31
-69.07
-173.62
24
A
ILE
36
-147.35
-35.10
24
A
ALA
39
-149.78
26.15
24
A
LYS
41
-147.21
-42.06
24
A
ASP
42
-146.74
10.98
24
A
PHE
59
-85.03
-71.14
24
A
THR
67
-86.51
46.31
24
A
ARG
68
-95.49
-61.95
24
A
ALA
72
-147.38
-35.13
24
A
THR
73
-50.47
175.66
24
A
LYS
88
-48.54
-16.87
24
A
ARG
89
-87.39
-75.02
24
A
TRP
95
-48.45
-14.35
24
A
LEU
97
-59.87
-1.54
24
A
ALA
98
-83.70
-72.57
24
A
ASN
101
-72.21
-75.39
24
A
CYS
103
-164.95
68.25
24
A
LYS
106
-92.59
-107.15
24
A
ASP
109
-88.68
-111.32
24
A
GLU
114
-71.66
-76.88
24
A
LYS
130
-171.01
-153.58
24
A
CYS
131
-48.61
-19.86
24
A
SER
132
-90.47
36.07
25
A
ALA
2
-54.90
-171.26
25
A
ALA
4
-178.07
-31.11
25
A
LYS
6
-75.66
39.29
25
A
CYS
28
-59.73
-4.08
25
A
LEU
31
-60.19
-171.47
25
A
ALA
39
-162.00
89.11
25
A
LYS
41
-137.70
-82.50
25
A
THR
43
-69.90
-179.97
25
A
PHE
59
-85.08
-72.55
25
A
THR
67
-93.90
42.28
25
A
ARG
89
-85.78
-73.60
25
A
LEU
94
-56.96
-71.14
25
A
LEU
97
-59.77
-1.55
25
A
ALA
98
-80.89
-73.08
25
A
ASN
101
-92.45
-70.18
25
A
CYS
103
-162.31
68.24
25
A
LYS
106
-93.02
-119.48
25
A
ASP
109
-92.53
-116.93
25
A
GLU
114
-68.63
-77.38
25
A
LYS
130
-175.69
-114.24
26
A
ALA
2
-162.86
54.43
26
A
CYS
28
-66.82
6.66
26
A
ALA
38
-61.94
0.34
26
A
ALA
39
-164.36
62.54
26
A
LYS
41
-153.15
-83.80
26
A
PHE
59
-85.12
-71.35
26
A
GLU
64
-47.37
-16.15
26
A
THR
67
-90.61
47.15
26
A
ALA
72
-148.63
-37.04
26
A
ARG
89
-85.37
-72.17
26
A
LEU
97
-59.66
-1.40
26
A
ALA
98
-78.38
-71.95
26
A
ASN
101
-92.96
-71.08
26
A
CYS
103
-161.11
68.00
26
A
LYS
106
-92.70
-130.09
26
A
ALA
108
170.01
159.19
26
A
ASP
109
-93.14
-122.27
26
A
GLU
114
-65.04
-73.49
26
A
LYS
130
-175.35
-114.89
26
A
SER
132
-87.26
35.95
27
A
GLU
3
-161.39
-95.30
27
A
ALA
4
-155.72
-28.83
27
A
HIS
5
-69.74
95.95
27
A
CYS
28
-64.23
3.08
27
A
ALA
39
-164.87
19.98
27
A
LYS
41
-145.07
-90.41
27
A
PHE
59
-84.97
-71.56
27
A
THR
67
-93.12
41.11
27
A
ALA
72
-147.82
-35.33
27
A
THR
73
-49.76
154.76
27
A
ARG
89
-77.07
-70.73
27
A
LEU
97
-59.61
-1.58
27
A
ALA
98
-82.58
-74.05
27
A
ASN
101
-93.01
-63.95
27
A
CYS
103
-165.02
68.24
27
A
LYS
106
-92.47
-114.54
27
A
ALA
108
-178.86
-169.97
27
A
ASP
109
-86.83
-123.60
27
A
LYS
130
-147.43
-144.20
28
A
ALA
2
-177.33
-94.67
28
A
HIS
5
-55.64
-169.83
28
A
LYS
6
-157.51
0.66
28
A
CYS
28
-58.95
-4.36
28
A
ASP
35
-49.84
168.78
28
A
ILE
36
-146.33
-34.78
28
A
LYS
41
-139.27
-77.86
28
A
PHE
59
-85.05
-72.39
28
A
GLU
64
-47.38
-18.79
28
A
THR
67
-92.48
44.71
28
A
LEU
70
-94.36
-64.12
28
A
ARG
89
-85.69
-72.10
28
A
LEU
94
-53.43
-71.56
28
A
TRP
95
-49.46
-12.86
28
A
LEU
97
-59.78
-1.65
28
A
CYS
103
-165.01
68.11
28
A
LYS
106
-81.07
-122.70
28
A
ASP
109
-92.68
-111.47
28
A
GLU
114
-70.64
-79.55
28
A
LYS
130
-175.21
-114.82
28
A
SER
132
-91.91
36.24
29
A
ALA
2
-157.61
13.14
29
A
ALA
4
-164.90
107.43
29
A
THR
26
-92.90
-152.62
29
A
LEU
31
-61.50
-169.85
29
A
ALA
39
-159.82
45.69
29
A
ASP
42
-149.55
24.44
29
A
PHE
59
-83.83
-70.03
29
A
THR
67
-76.70
36.94
29
A
ALA
72
-147.35
-35.13
29
A
THR
73
-54.32
171.11
29
A
ARG
89
-80.35
-72.01
29
A
LEU
97
-59.84
-1.39
29
A
ASN
101
-92.55
-63.61
29
A
CYS
103
-164.97
68.24
29
A
LYS
106
-139.09
-127.60
29
A
ALA
108
179.80
-170.24
29
A
ASP
109
-78.99
-130.86
29
A
GLU
114
-74.29
-72.67
29
A
TYR
128
-67.36
4.78
29
A
SER
129
-74.42
22.17
29
A
LYS
130
-75.92
-104.93
29
A
SER
132
-95.77
-155.47
30
A
ALA
2
-166.87
-168.34
30
A
ALA
4
-177.62
-28.22
30
A
LYS
6
-63.50
2.05
30
A
GLU
30
-57.03
-5.55
30
A
LYS
41
-136.99
-46.16
30
A
ASP
42
-93.49
31.17
30
A
THR
44
-92.57
-139.11
30
A
THR
67
-87.94
44.35
30
A
ARG
68
-99.71
-60.74
30
A
ALA
72
-147.37
-35.55
30
A
THR
73
-69.73
-179.09
30
A
LEU
94
-48.39
-72.12
30
A
ASN
101
-92.21
-90.36
30
A
CYS
103
-164.97
68.10
30
A
LYS
106
-92.85
-128.73
30
A
ALA
108
-154.53
-153.50
30
A
ASP
109
-91.42
-126.63
30
A
GLU
114
-68.83
-76.93
30
A
TYR
128
-64.83
3.70
30
A
LYS
130
-174.88
-114.41
31
A
ALA
2
-160.85
-8.87
31
A
GLU
3
-64.83
-92.34
31
A
HIS
5
-146.46
57.01
31
A
CYS
28
-64.67
0.62
31
A
LEU
31
-60.98
-172.43
31
A
ALA
39
-148.17
36.73
31
A
LYS
41
-149.43
-88.74
31
A
THR
44
-84.23
-136.53
31
A
ARG
57
-62.86
-71.95
31
A
PHE
59
-81.13
-72.57
31
A
THR
67
-77.48
48.12
31
A
ARG
68
-97.69
-66.00
31
A
ALA
72
-147.75
-35.32
31
A
THR
73
-69.81
-179.51
31
A
LEU
97
-59.46
-2.24
31
A
CYS
103
-165.02
68.20
31
A
LYS
106
-92.57
-114.10
31
A
ASP
109
-90.72
-120.19
31
A
GLU
114
-73.14
-78.81
31
A
TYR
128
-66.21
5.52
31
A
LYS
130
-157.20
-102.01
31
A
SER
132
-84.26
37.12
THE HIGH RESOLUTION THREE-DIMENSIONAL SOLUTION STRUCTURE OF HUMAN INTERLEUKIN-4 DETERMINED BY MULTI-DIMENSIONAL HETERONUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
1
Y
N
A
ASP
8
A
ASP
8
HELX_P
A
GLN
24
A
GLN
24
1
1
17
A
THR
26
A
THR
26
HELX_P
A
GLU
30
A
GLU
30
5
2
5
A
ILE
36
A
ILE
36
HELX_P
A
SER
40
A
SER
40
5
3
5
A
THR
44
A
THR
44
HELX_P
A
HIS
63
A
HIS
63
1
4
20
A
THR
73
A
THR
73
HELX_P
A
GLY
99
A
GLY
99
1
5
27
A
LEU
113
A
LEU
113
HELX_P
A
TYR
128
A
TYR
128
1
6
16
disulf
2.021
A
CYS
7
A
SG
CYS
7
1_555
A
CYS
131
A
SG
CYS
131
1_555
disulf
2.020
A
CYS
28
A
SG
CYS
28
1_555
A
CYS
69
A
SG
CYS
69
1_555
disulf
2.021
A
CYS
50
A
SG
CYS
50
1_555
A
CYS
103
A
SG
CYS
103
1_555
CYTOKINE
INTERLEUKIN-4, CYTOKINE
IL4_HUMAN
UNP
1
1
P05112
MGLTSQLLPPLFFLLACAGNFVHGHKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKNTTEKETFCRAATVLRQFY
SHHEKDTRCLGATAQQFHRHKQLIRFLKRLDRNLWGLAGLNSCPVKEANQSTLENFLERLKTIMREKYSKCSS
25
153
1ITI
5
133
P05112
A
1
5
133
1
ASN
conflict
ASP
42
1ITI
A
P05112
UNP
62
42
1
ASN
conflict
ASP
109
1ITI
A
P05112
UNP
129
109
2
anti-parallel
A
THR
32
A
THR
32
A
VAL
33
A
VAL
33
A
SER
111
A
SER
111
A
THR
112
A
THR
112
1
P 1